AccuStem Sciences, Inc.
(Note: This is NOT an IPO. This is a NASDAQ uplisting from the OTCQB Venture Market.) Our mission is to provide novel diagnostic tools that optimize outcomes and quality of life for all patients along the continuum of oncology care, from cancer screening through treatment and monitoring. We have one wholly owned subsidiary: StemPrintER Sciences […]
November 17, 2022 Read More